IL-23 Responsive Innate-Like T Cells in Spondyloarthritis: the Less Frequent They Are, the More Vital They Appear
出版年份 2015 全文链接
标题
IL-23 Responsive Innate-Like T Cells in Spondyloarthritis: the Less Frequent They Are, the More Vital They Appear
作者
关键词
Spondyloarthritis, IL-23, RORγt, IL-17, Innate-like T cells, TCRγδ T cells, KIR3DL2<sup>+</sup>CD4<sup>+</sup> T cells, iNKT cells
出版物
Current Rheumatology Reports
Volume 17, Issue 5, Pages -
出版商
Springer Nature
发表日期
2015-04-14
DOI
10.1007/s11926-015-0507-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Integrating the pathogenesis of spondyloarthritis
- (2015) Katelijne De Wilde et al. CURRENT OPINION IN RHEUMATOLOGY
- Commensal microbiota influence systemic autoimmune responses
- (2015) J. T. Van Praet et al. EMBO JOURNAL
- Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial
- (2014) Christopher Ritchlin et al. ANNALS OF THE RHEUMATIC DISEASES
- Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS)
- (2014) Denis Poddubnyy et al. ANNALS OF THE RHEUMATIC DISEASES
- The interleukin-23/interleukin-17 immune axis as a promising new target in the treatment of spondyloarthritis
- (2014) Nataliya Yeremenko et al. CURRENT OPINION IN RHEUMATOLOGY
- The Identification of the Endogenous Ligands of Natural Killer T Cells Reveals the Presence of Mammalian α-Linked Glycosylceramides
- (2014) Lisa Kain et al. IMMUNITY
- A178: Development of Tools to Facilitate Shared Decision Making about Medications for Juvenile Idiopathic Arthritis-A Project of the Pediatric Rheumatology Care and Outcomes Improvement Network
- (2014) Esi Morgan DeWitt et al. Arthritis & Rheumatology
- The Concept of Axial Spondyloarthritis: Joint Statement of the Spondyloarthritis Research and Treatment Network and the Assessment of SpondyloArthritis international Society in Response to the US Food and Drug Administration's Comments and Concerns
- (2014) Atul Deodhar et al. Arthritis & Rheumatology
- Interleukin-23 Mediates the Intestinal Response to Microbial β-1,3-Glucan and the Development of Spondyloarthritis Pathology in SKG Mice
- (2014) Helen Benham et al. Arthritis & Rheumatology
- Autoantibodies against CD74 in spondyloarthritis
- (2013) N T Baerlecken et al. ANNALS OF THE RHEUMATIC DISEASES
- Senescence marker killer cell lectin-like receptor G1 (KLRG1) contributes to TNF-α production by interaction with its soluble E-cadherin ligand in chronically inflamed joints
- (2013) Lode Melis et al. ANNALS OF THE RHEUMATIC DISEASES
- Evidence that autophagy, but not the unfolded protein response, regulates the expression of IL-23 in the gut of patients with ankylosing spondylitis and subclinical gut inflammation
- (2013) Francesco Ciccia et al. ANNALS OF THE RHEUMATIC DISEASES
- Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells
- (2013) Peggy Jacques et al. ANNALS OF THE RHEUMATIC DISEASES
- Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up
- (2013) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- Natural Killer T cell obsession with self-antigens
- (2013) Laurent Gapin et al. CURRENT OPINION IN IMMUNOLOGY
- Th17 cell development: from the cradle to the grave
- (2013) Luis A. Zúñiga et al. IMMUNOLOGICAL REVIEWS
- Induced IL-17-Producing Invariant NKT Cells Require Activation in Presence of TGF- and IL-1
- (2013) M. Monteiro et al. JOURNAL OF IMMUNOLOGY
- Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial
- (2013) Iain B McInnes et al. LANCET
- Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial
- (2013) Dominique Baeten et al. LANCET
- Inflammatory pathways in spondyloarthritis
- (2013) Hulda S. Hreggvidsdottir et al. MOLECULAR IMMUNOLOGY
- Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci
- (2013) Adrian Cortes et al. NATURE GENETICS
- Steady-state production of IL-4 modulates immunity in mouse strains and is determined by lineage diversity of iNKT cells
- (2013) You Jeong Lee et al. NATURE IMMUNOLOGY
- How Cytokine Networks Fuel Inflammation: Toward a cytokine-based disease taxonomy
- (2013) Georg Schett et al. NATURE MEDICINE
- Association Between Life Events and Rheumatoid Arthritis: Results From a Population-Based Case-Control Study
- (2013) Annmarie Wesley et al. ARTHRITIS CARE & RESEARCH
- Microscopic gut inflammation in axial spondyloarthritis: a multiparametric predictive model
- (2012) Liesbet Van Praet et al. ANNALS OF THE RHEUMATIC DISEASES
- Mo2083 A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
- (2012) Stephan R. Targan et al. GASTROENTEROLOGY
- Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
- (2012) Wolfgang Hueber et al. GUT
- Enhanced Peptide Identification by Electron Transfer Dissociation Using an Improved Mascot Percolator
- (2012) James C. Wright et al. MOLECULAR & CELLULAR PROTEOMICS
- IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4−CD8− entheseal resident T cells
- (2012) Jonathan P Sherlock et al. NATURE MEDICINE
- Genetics of spondyloarthritis—beyond the MHC
- (2012) John D. Reveille Nature Reviews Rheumatology
- Invariant natural killer T cells as sensors and managers of inflammation
- (2012) Luc Van Kaer et al. TRENDS IN IMMUNOLOGY
- Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive γ/δ T cells in patients with active ankylosing spondylitis
- (2011) Tony J. Kenna et al. ARTHRITIS AND RHEUMATISM
- Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection
- (2011) Manfred Brigl et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Proinflammatory Environment Dictates the IL-17-Producing Capacity of Human Invariant NKT Cells
- (2011) L. Moreira-Teixeira et al. JOURNAL OF IMMUNOLOGY
- Th17 Cells Expressing KIR3DL2+ and Responsive to HLA-B27 Homodimers Are Increased in Ankylosing Spondylitis
- (2011) P. Bowness et al. JOURNAL OF IMMUNOLOGY
- The IL23R R381Q Gene Variant Protects against Immune-Mediated Diseases by Impairing IL-23-Induced Th17 Effector Response in Humans
- (2011) Paola Di Meglio et al. PLoS One
- Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+ and CD8+ human T-cell functional responses
- (2011) R. Sarin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general
- (2010) M. Rudwaleit et al. ANNALS OF THE RHEUMATIC DISEASES
- Invariant natural killer T cells are natural regulators of murine spondylarthritis
- (2010) Peggy Jacques et al. ARTHRITIS AND RHEUMATISM
- Interleukin-23 Drives Intestinal Inflammation through Direct Activity on T Cells
- (2010) Philip P. Ahern et al. IMMUNITY
- γδ T Cells Enhance Autoimmunity by Restraining Regulatory T Cell Responses via an Interleukin-23-Dependent Mechanism
- (2010) Franziska Petermann et al. IMMUNITY
- Invariant natural killer T cells in rheumatic disease: a joint dilemma
- (2010) Michael B. Drennan et al. Nature Reviews Rheumatology
- Endoplasmic reticulum stress-induced transcription factor, CHOP, is crucial for dendritic cell IL-23 expression
- (2010) Jane C. Goodall et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritis
- (2009) L. Melis et al. ANNALS OF THE RHEUMATIC DISEASES
- HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats
- (2009) Monica L. DeLay et al. ARTHRITIS AND RHEUMATISM
- Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis
- (2009) Francesco Ciccia et al. ARTHRITIS AND RHEUMATISM
- Interleukin-17-Producing γδ T Cells Selectively Expand in Response to Pathogen Products and Environmental Signals
- (2009) Bruno Martin et al. IMMUNITY
- Interleukin-1 and IL-23 Induce Innate IL-17 Production from γδ T Cells, Amplifying Th17 Responses and Autoimmunity
- (2009) Caroline E. Sutton et al. IMMUNITY
- Cutting Edge: IL-23 Receptor GFP Reporter Mice Reveal Distinct Populations of IL-17-Producing Cells
- (2009) Amit Awasthi et al. JOURNAL OF IMMUNOLOGY
- CD27 is a thymic determinant of the balance between interferon-γ- and interleukin 17–producing γδ T cell subsets
- (2009) Julie C Ribot et al. NATURE IMMUNOLOGY
- Joint expedition: linking gut inflammation to arthritis
- (2008) P Jacques et al. Mucosal Immunology
- Critical role of ROR- t in a new thymic pathway leading to IL-17-producing invariant NKT cell differentiation
- (2008) M.-L. Michel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1- NKT cell population
- (2008) J. M. Coquet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More